We also interrogated expression data from relapsed2 and metastatic40 neuroblastoma tumors, which had paired primary tumor data and we identified no evidence of depletion of TOP2B expression in metastases or relapse (Fig. 5E−F). The gene discussed is TOP2B; the disease is neuroblastoma.